• BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Consensus Rating of "Moderate Buy" by Analysts

    Source: Buzz FX / 17 Feb 2025 01:56:12   America/Chicago


    BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat February 17, 2025 Share Link copied to clipboard. Shares of BioCryst Pharmaceuticals, Inc.
    Read more...
Share on,